Familial Cancer

Papers
(The median citation count of Familial Cancer is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Laboratory variation in the grading of dysplasia of duodenal adenomas in familial adenomatous polyposis patients28
Prevalence of cardiometabolic outcomes in women who underwent salpingo-oophorectomy to prevent hereditary breast and ovarian cancer: a meta-analysis19
Colonoscopy surveillance in Lynch syndrome is burdensome and frequently delayed17
Cascade genetic testing: an underutilized pathway to equitable cancer care?16
Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery15
Hereditary breast and ovarian cancer genetic testing in unselected patients: example of private supplementation of public healthcare service15
Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review12
Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review12
Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants12
Collaborative Group of the Americas on Inherited Gastrointestinal Cancers (CGA-IGC) Annual Virtual Meeting, November 13–15, 202111
Detection of a major Lynch Syndrome-causing MLH1 founder variant in a large-scale genotyped cohort10
Monoallelic MUTYH pathogenic variants ascertained via multi-gene hereditary cancer panels are not associated with colorectal, endometrial, or breast cancer10
Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study10
Clinician perspectives on policy approaches to genetic risk disclosure in families10
Misclassification of a frequent variant from PMS2CL pseudogene as a PMS2 loss of function variant in Brazilian patients9
The genetic landscape of Lynch syndrome in the Israeli population7
Functional and phenotypic consequences of an unusual inversion in MSH27
Overlap syndrome of hereditary hemorrhagic telangiectasia and juvenile polyposis syndrome: ten years follow-up-case series and review of literature7
Impact of hormonal contraception on endometrial histology in patients with Lynch syndrome, a retrospective pilot study7
Haplotype analysis detects MLH1 founder variant in Indian Lynch syndrome patient cohort7
Progress report: Peutz–Jeghers syndrome7
The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants6
Mainstreamed genetic testing of breast cancer patients: experience from a single surgeon’s practice in a large US Academic Center6
The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review6
Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy6
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature6
Balancing the burden and benefits of colonoscopy in Lynch Syndrome6
In memoriam: Gloria Petersen, PhD (1950-2023)6
Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome6
Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs6
Correction: Benign tumors and non-melanoma skin cancers in patients with fanconi anemia6
Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH16
A case of Rothmund-Thomson syndrome originally thought to be a case of Bloom syndrome6
Hepatocellular carcinoma and solid pseudopapillary neoplasm of the pancreas complicating familial adenomatous polyposis: two cases and review of the literature6
Risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer in women with an increased inherited risk: insights into an alternative strategy6
Mainstreaming cancer genetics: feasibility of an advanced nurse practitioner-led service diagnosing Lynch syndrome from colorectal cancer in Ireland5
Prevalence and risk factors of barrett’s esophagus in lynch syndrome5
Whole genome sequencing and disease pattern in patients with juvenile polyposis syndrome: a nationwide study5
Aberrant transcription caused by an intronic non-canonical CDH1 variant5
Colectomy and desmoid tumours in familial adenomatous polyposis: a systematic review and meta-analysis5
Addressing uncertainty in hereditary colorectal cancer: the role of a regional expert multidisciplinary team meeting5
PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer5
Heritable methylation marks associated with prostate cancer risk4
A large family with MSH3-related polyposis4
Universal tumor screening for lynch syndrome on colorectal cancer biopsies impacts surgical treatment decisions4
In Memoriam: Steffen Bülow (1943–2023)4
Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO4
Evaluation of EGFR and COX pathway inhibition in human colon organoids of serrated polyposis and other hereditary cancer syndromes4
The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals4
Benign tumors and non-melanoma skin cancers in patients with Fanconi anemia4
Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow4
Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre3
Familial pancreatic cancer: a long fruitful journey3
Clinical and genetic characteristics of carriers of the TP53 c.541C > T, p.Arg181Cys pathogenic variant causing hereditary cancer in patients of Arab-Muslim descent3
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer3
Recurring pathogenic variants in the BRCA2 gene in the Ethiopian Jewish population. Founder mutations?3
Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant3
The 17th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC)3
In deep bioinformatic characterization of a novel fumarate hydratase variant FH c.199T > G; (p.Tyr67Asp) in hereditary leiomyomatosis and renal cell carcinoma3
Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family3
Endoscopic indicators in patients with familial adenomatous polyposis undergoing duodenal resections – a nationwide Danish cohort study with long-term follow-up3
Report of the sixth meeting of the European Consortium ‘Care for CMMRD’ (C4CMMRD), Paris, France, November 16th 20223
Germline whole genome sequencing in adults with multiple primary tumors3
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake3
Thirty-year compliance with a surveillance program for patients with familial adenomatous polyposis3
InSiGHT 2022 Abstract Publishing and Best Abstract Awards2
A PMS2 non-canonical splicing site variant leads to aberrant splicing in a patient suspected for lynch syndrome2
Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?2
Characteristics of familial pancreatic cancer families with additional colorectal carcinoma2
Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility2
Physicians’ experience, practice and education, on genetic testing and genetic counseling: a nationwide survey study in Greece2
Somatic STK11 mosaicism in a Turkish patient with Peutz-Jeghers syndrome2
New RPS20 gene variant in colorectal cancer diagnosis: insight from a large series of patients2
A need to tailor surveillance based on family history: describing a highly penetrant familial paraganglioma kindred with an SDHD pathogenic variant2
Reclassification of two germline DICER1 splicing variants leads to DICER1 syndrome diagnosis2
Bilateral familial retinoblastoma diagnosed via optical coherence tomography following a normal funduscopic exam2
Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome2
Molecular characterization of an embryonal rhabdomyosarcoma occurring in a patient with Kabuki syndrome: report and literature review in the light of tumor predisposition syndromes2
Willingness of individuals with Li-Fraumeni syndrome to participate in a cancer prevention trial: a survey study2
BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories2
A family-based approach to cascade genetic testing in a pediatric cancer genetics clinic2
Complications of colonoscopy surveillance of patients with Lynch syndrome – 33 years of follow up2
Recurrent paraneoplastic nephrotic syndrome; insights from a Lynch syndrome patient with multiple malignancies2
Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women2
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants2
CHEK2-related breast cancer: real-world challenges2
Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer2
Detecting inversions in routine molecular diagnosis in MMR genes2
Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups2
2022 CGA-IGC Annual Meeting: The collaborative group of the Americas on Inherited Gastrointestinal Cancer November 11–13, 20222
Intestinal and extraintestinal neoplasms in patients with NTHL1 tumor syndrome: a systematic review2
0.31279587745667